NYSE:AS

Amer Sports (NYSE:AS) Q1 Earnings Soar Past Estimates with Strong Revenue Growth

Font: Financial Modeling Prep  • May 19, 2026

Market Chart
  • Strong Q1 Performance: Amer Sports significantly surpassed analyst expectations for both earnings per share and revenue in Q1 2026.
  • Robust Revenue Growth: The company reported a 32% year-over-year revenue increase, driven by key brands like Arc'teryx and Salomon.
  • Solid Financial Health: Amer Sports maintains a low debt-to-equity ratio and a healthy current ratio, indicating strong financial stability.

Amer Sports (NYSE:AS) is a global company that manages a portfolio of well-known sports and outdoor brands. Its main activities involve designing and selling technical apparel, footwear, and equipment. Key brands under its umbrella include Arc'teryx, Salomon, and Wilson, which compete for market share in their respective segments.

On May 19, 2026, Amer Sports announced its first-quarter financial results. The company reported an earnings per share (EPS) of $0.38. This figure surpassed the analyst consensus estimate of $0.31. As highlighted by Zacks, this also represents a significant improvement from the $0.27 per share earned in the same quarter last year.

The company also posted strong revenue of $1.95 billion, which was higher than the estimated $1.84 billion. According to its first quarter report mentioned by Business Wire, this marks a 32% increase in revenue compared to the previous year. This is the fourth straight quarter that Amer Sports has beaten estimates for both earnings and revenue.

This growth was driven by strong performance across its brands. The Technical Apparel segment, led by Arc'teryx, saw its revenue climb by 33% to $885 million. CEO James Zheng noted that accelerating demand for Salomon softgoods and continued strength in Wilson Tennis also contributed to the positive results.

From a financial health perspective, Amer Sports maintains a low level of debt with a debt-to-equity ratio of 0.42. This ratio compares a company's total debt to its total shareholder equity. The company also has a current ratio of 1.50, indicating it has sufficient assets to cover its short-term liabilities.

Market Overview
TZA
Direxion Daily Small Cap Bear 3X ETF
$4.83
-7.29%
SLXN
Silexion Therapeutics Ltd.
$0.53
96.95%
HAO
Haoxi Health Technology Limited
$0.01
0.71%
SOXS
Direxion Daily Semiconductor Bear 3X ETF
$8.54
-14.00%
MEHA
Functional Brands, Inc. Common Stock
$0.09
21.95%
JUNS
Jupiter Neurosciences, Inc.
$0.21
-35.94%
PHGE
BiomX Inc.
$0.60
59.60%
WOK
WORK Medical Technology Group Ltd.
$0.19
-19.57%
HCWB
HCW Biologics Inc.
$2.43
129.25%
GDC
GD Culture Group Limited
$0.12
-17.44%